The American Thoracic Society (ATS), the world’s leading professional organization dedicated to advancing the understanding and treatment of respiratory disease, critical illness, and sleep disorders, has officially inaugurated a new leadership chapter. Michelle Ng Gong, MD, MS, ATSF, has assumed the role of president, taking over the mantle from Raed Dweik, MD, MBA, ATSF. This transition marks a significant milestone for the organization as it looks toward a future defined by increased mentorship, advocacy, and interdisciplinary clinical excellence.
The Core Transition: Leadership Continuity and Vision
The succession of Dr. Michelle Ng Gong as the president of the ATS is not merely a change in administrative leadership; it is a strategic alignment with the society’s long-term goal of fostering the next generation of respiratory specialists. Dr. Gong, a distinguished physician-scientist with a career defined by rigorous clinical investigation and academic leadership, steps into the role during a period of rapid evolution in pulmonary and critical care medicine.
Dr. Dweik, who has overseen the society through a tenure characterized by the integration of emerging technologies and post-pandemic recovery strategies, leaves a legacy of operational stability. Dr. Gong inherits an organization that has become increasingly influential in setting international standards for clinical practice, medical education, and public policy. Her immediate agenda focuses on the professional development of the society’s diverse membership base, which includes physicians, researchers, nurses, and respiratory therapists.
Chronology: A Career Built on Clinical and Academic Excellence
To understand the trajectory of Dr. Gong’s leadership, one must look at the foundation of her medical career. Dr. Gong’s professional journey has been characterized by a steady ascent through the ranks of academic medicine, marked by a commitment to the complexities of critical care.
Early Membership and Foundational Work
Dr. Gong’s relationship with the American Thoracic Society began in 1998, a time when the field of critical care medicine was undergoing a massive paradigm shift in the management of acute respiratory distress syndrome (ARDS) and sepsis. Joining the Critical Care Assembly early in her career allowed her to contribute to the foundational discussions that would eventually shape modern intensive care unit (ICU) protocols.
Institutional Leadership at Montefiore and Einstein
Her clinical expertise is anchored at the Montefiore Medical Center and the Albert Einstein College of Medicine. Serving as the Chair of Medicine at these prestigious institutions, Dr. Gong has navigated the unique challenges of treating medically underserved populations, a perspective she brings to the national stage. Prior to her current role, she served as the Chief of the Division of Critical Care Medicine and the Chief of the Division of Pulmonary Medicine, providing her with a comprehensive understanding of the operational and clinical requirements of hospital-based specialties.
The Rise to the Executive Committee
Over the past decade, Dr. Gong’s involvement with the ATS executive committee has seen her move from an active member to a strategic architect. Her role on the committee has involved oversight of the society’s massive publishing arm, its global advocacy efforts, and its internal governance structures. Her appointment to the presidency is the culmination of years of dedicated service to the society’s board of directors, where she has been instrumental in formulating the organization’s current strategic priorities.
Supporting Data: The Scope of the American Thoracic Society
The ATS is a powerhouse in the medical community, and its new president will be managing an organization with a reach that extends far beyond the United States.
- Global Membership: The society boasts a membership of thousands of professionals globally, representing more than 100 countries.
- Scientific Impact: Through its journals—including the American Journal of Respiratory and Critical Care Medicine (AJRCCM)—the ATS influences clinical practice guidelines that are adopted worldwide.
- Advocacy: The ATS invests heavily in lobbying efforts regarding air quality, public health policy, and federal funding for medical research (NIH/NHLBI).
- The Critical Care Assembly: As a key member of this specific assembly, Dr. Gong represents one of the largest and most active divisions within the society, which focuses on the management of life-threatening respiratory conditions.
The society’s resources, which Dr. Gong intends to leverage for member growth, include an extensive network of peer-reviewed content, grant-writing workshops, and career-advancement forums designed to bridge the gap between fellowship and senior faculty positions.
Official Responses and Strategic Vision
During her inauguration, Dr. Gong emphasized that the strength of the ATS lies in the "depth of expertise" held by its individual members. In an era where burnout in the medical profession has reached record levels, her focus on career trajectories and mentorship is both timely and essential.
"Our members have a great depth of expertise in research, clinical expertise, career guidance, and setting guidelines in advocacy, policy, and environment," Dr. Gong stated. She highlighted that the society’s internal resources are currently underutilized by many early- and mid-career investigators. "Some of our members are not just leaders within the field of pulmonary and critical care but are oftentimes leaders at their own institutions. We must create a pipeline that allows our younger members to tap into that mentorship."
Her vision includes:
- Professional Development: Creating new mentorship pathways for clinicians navigating the transition from training to independent practice.
- Resource Accessibility: Streamlining access to research grants and institutional networking opportunities.
- Institutional Leadership: Empowering ATS members to take on administrative roles within their own healthcare systems, thereby increasing the footprint of pulmonary and critical care expertise in hospital governance.
Implications: The Future of Pulmonary and Critical Care
The appointment of Dr. Gong carries significant implications for the future of respiratory health. As the medical community faces ongoing challenges—ranging from the lingering effects of COVID-19 to the rising prevalence of chronic obstructive pulmonary disease (COPD) and the environmental impact on lung health—the ATS is positioned to lead the national dialogue.
A Focus on Interdisciplinary Collaboration
Dr. Gong’s background in both pulmonary and critical care suggests that the society will continue to promote a holistic approach to patient care. This involves integrating the latest diagnostic technologies with long-term patient management strategies.
Policy and Advocacy
Under her leadership, it is expected that the ATS will intensify its focus on environmental health. Given the rising rates of asthma and other respiratory issues linked to climate change and air pollution, the society is likely to expand its role in federal advocacy, pushing for more stringent clean-air regulations and funding for research into environmental triggers for lung disease.
Addressing the Career Pipeline
One of the most pressing issues in modern medicine is the shortage of specialists in pulmonary and critical care. By prioritizing the career trajectories of mid-investigators, Dr. Gong is addressing a critical bottleneck in the medical workforce. Her strategy involves making the society more than just a source of clinical guidelines; it aims to become a career-long partner for its members, providing the tools necessary for both academic success and clinical efficacy.
Conclusion: A Steady Hand for a Changing Field
The American Thoracic Society stands at a crossroads. As it balances the demands of rapid clinical advancement with the need for sustainable medical practice, the leadership of Michelle Ng Gong provides both continuity and fresh perspective. With her deep roots in the organization and her extensive experience at the bedside and in the boardroom, Dr. Gong is uniquely qualified to steer the ATS through the complexities of the modern healthcare landscape.
As she assumes the presidency, the focus remains clear: supporting the clinicians and researchers who serve as the frontline defenders of respiratory health. Through her commitment to mentorship and institutional empowerment, Dr. Gong is set to leave a lasting mark on the society, ensuring that the ATS remains a vital, influential, and supportive force for all those dedicated to the science and practice of lung health.
